Jing Guo, Research Scientist, MITThis interview features: Jing Guo, Research Scientist, MIT, from BioProcess International 2023.

Ingress of carbon dioxide into bulk drug substance (BDS) containers that are stored and shipped on dry ice is a serious and often understated problem. Bottles are a container of choice for freezing ...

Learn about a new purification approach starting from E. coli through to mRNA production, resulting in improved recoveries, extra-low protein impurities, and very efficient dsRNA removal.

Boehringer bolsters ADC biz with $1.3bn Synaffix deal Germany-based pharmaceutical giant Boehringer Ingelheim has licensed antibody drug conjugate (ADC) technology from Lonza’s Synaffix.

Lee Willmon, HSE Operations, Novartis, from BPI West 2024.

Explore the latest news and expert commentary by Inês do Carmo Gonçalves, brought to you by the Contributor of BioProcess International.

You want to scale and deliver your vaccine to the world quickly. Our collaborative global vaccine capabilities will take your innovation from pre-clinical to full-scale GMP-manufacturing efficiently, ...

Working with the right partner for cell & gene therapies can help ease the increasingly common problems with scale, access to high-demand raw material, viral vector production, and quality ...

Vaccines have been protecting against disease since the late 1700s. They function by triggering the immune system to generate short-term and long-term responses. Because there are many pathogens, ...

Wilkinson talks about the development of mass photometry, how it advances the field of biomolecular analysis, and more.

Learn about the numerous benefits of using a high-quality GMP-grade plasmid platform when manufacturing your pharmaceuticals.

Vaxcyte cites manufacturing investments as key 2024 expenditure The vaccine developer ramps up manufacturing as clinical trials head into Phase III.